Location History:
- 1200 Brussels, BE (1988)
- Brussels, BE (1977 - 1996)
Company Filing History:
Years Active: 1977-1996
Title: The Innovative Journey of Inventor Pierre L Masson
Introduction
Pierre L Masson, located in Brussels, Belgium, is a prolific inventor renowned for his significant contributions in the field of pharmaceuticals. With a total of 19 patents to his name, Masson's work focuses on developing compositions and methods that have the potential to enhance medical treatments and patient care.
Latest Patents
Among his latest patents are two noteworthy inventions. The first is a pharmaceutical composition aimed at suppressing the production of factor VIII inhibitor. This innovative composition is suitable for administration to human beings, addressing critical needs in medical treatments for various conditions. The second patent revolves around a treatment for allergies, presenting a pharmaceutical composition that consists of an immune complex of an allergen and a purified antibody specific to that allergen. This composition targets immediate hypersensitivity mediated by IgE antibodies, offering a new avenue for alleviating allergic reactions.
Career Highlights
Masson has had a distinguished career, having worked with notable companies such as Technicon Instruments Corporation and the International Institute of Cellular and Molecular Pathology. His experiences in these esteemed organizations have greatly contributed to his expertise and the development of his patented innovations.
Collaborations
Throughout his career, Masson has collaborated with several gifted professionals, including Cesar L Cambiaso and Daniel Collet-Cassart. These partnerships have enabled him to enhance his research and bring his innovative ideas to fruition.
Conclusion
Pierre L Masson's impressive portfolio of patents reflects his commitment to advancing medical science. His latest inventions promise to make significant impacts in the treatment of complex health issues such as allergies and blood coagulation disorders. As he continues his work, the medical community eagerly awaits the future innovations he will contribute.